Polymers in Medicine

Polim. Med.
Index Copernicus (ICV 2021) – 120.65
MNiSW – 70
Average rejection rate – 27.13%
ISSN 0370-0747 (print)
ISSN 2451-2699 (online) 
Periodicity – biannual

Download PDF

Polymers in Medicine

2019, vol. 49, nr 1, January-June, p. 19–26

doi: 10.17219/pim/111516

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Creative Commons BY-NC-ND 3.0 Open Access

Influence of sodium starch glycolate, croscarmellose sodium and crospovidone on disintegration and dissolution of stevia-loaded tablets

Abid Mehmood Yousaf1,D, Faiza Naheed2,B,C, Yasser Shahzad1,E,F, Talib Hussain1,E,F, Tariq Mahmood2,C,E,F

1 Department of Pharmacy, COMSATS University Islamabad, Lahore Campus, Pakistan

2 Faculty of Pharmacy, University of Central Punjab, Lahore, Pakistan


Background. Sugar substitutes are used by diabetic, obese and calorie-conscious people. As artificial sweeteners are harmful to the body, natural sweeteners are more suitable. Sugar substitutes are available on the market in tablet forms, which are added to hot or cold drinks. Rapid disintegration and dissolution of sugar substitute-loaded tablet is desired. However, the tablets should be hard enough to maintain their integrity during mechanical shocks.
Objectives. The objective of this research was to develop rapidly disintegrating and dissolving stevia-loaded tablets with appropriate wetting, hardness and friability.
Material and Methods. Several tablets were prepared using different superdisintegrants using the direct compression method. Flowability tests of the powder blends were performed before compression; these test took into account such physical parameters as bulk density, tapped density, angle of repose, compressibility index, and Hausner’s ratio. Evaluation of the compressed cores was accomplished with weight variation, hardness, thickness, friability, disintegration time, wetting time, and dissolution.
Results. The disintegration time and wetting time of the tablets were in the following order: sodium starch glycolate > croscarmellose sodium > crospovidone containing tablets. A powder blend consisting of stevia extract, crospovidone, lactose, and magnesium stearate at the optimized ratio of 15/2.5/32/0.5 (w/w/w/w) showed the best flow, rapid disintegration (38 ±0.894 s), wetting (30 ±1 s), and dissolution (~ 95% in 1 min). Moreover, this formulation showed more rapid wetting (30 ±1 s vs 91 ±1.9 s), disintegration (38 ±0.894 s vs 143 ±1.276 s) and dissolution (~ 95% vs 60% in 1 min) than a commercial product.
Conclusion. The tablet consisting of stevia, crospovidone, lactose, and magnesium stearate at the weight ratio of 15/2.5/32/0.5 showed excellent results with regards to dissolution and disintegration; accordingly, this formulation could be a potential sugar substitute for diabetic, obese and/or calorie-conscious individuals.

Key words

superdisintegrants, sugar substitute, hydrophilic polymers, wetting time

References (27)

  1. O’Keefe JH, Bell DSH. Postprandial hyperglycemia/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor. Am J Cardiol. 2007;100(5):899–904.
  2. Willett W, Manson J, Liu S. Glycemic index, glycemic load, and risk of type 2 diabetes. Am J Clin Nutr. 2002;76(1):274S–280S.
  3. Mattes RD, Popkin BM. Nonnutritive sweetener consumption in humans: Effects on appetite and food intake and their putative mechanisms. Am J Clin Nutr. 2009;89(1):1–14.
  4. Raben A, Vasilaras TH, Møller AC, Astrup A. Sucrose compared with artificial sweeteners: Different effects on ad libitum food intake and body weight after 10 wk of supplementation in overweight subjects. Am J Clin Nutr. 2002;76(4):721–729.
  5. Bellisle F, Drewnowski A. Intense sweeteners, energy intake and the control of body weight. Eur J Clin Nutr. 2007;61(6):691–700.
  6. Renwick AG. The intake of intense sweeteners: An update review. Food Addit Contam. 2006;23(4):327–338.
  7. Fitch C, Keim KS. Position of the Academy of Nutrition and Dietetics: Use of nutritive and nonnutritive sweeteners. J Acad Nutr Diet. 2012;112(5):739–758.
  8. Chang JC, Wu M, Liu IM, Cheng JT. Increase of insulin sensitivity by stevioside in fructose-rich chow-fed rats. Horm Metab Res. 2005;37(10):610–616.
  9. Gupta C, Prakash D, Gupta S, Goyal S. Role of low calorie sweeteners in maintaining dental health. Middle East J Sci Res. 2012;11(3):342–346.
  10. Duffy VB, Anderson G. Position of the American Dietetic Association: Use of nutritive and nonnutritive sweeteners. J Am Diet Assoc. 1998;98(5):580–587.
  11. Savita S, Sheela K, Sunanda S, Shankar A, Ramakrishna P, Sakey S. Health implications of Stevia rebaudiana. J Hum Ecol. 2004;15(3):191–194.
  12. Komissarenko N, Derkach A, Kovalyov I, Bublik N. Diterpene glycosides and phenylpropanoids of Stevia rebaudiana Bertoni. Rast Res. 1994;1(2):53–64.
  13. Soejarto D, Compadre C, Medon P, Kamath S, Kinghorn A. Stevia: Steps in developing a new sweeteners, developments in sweeteners. Econ Bot. 1983;37:71.
  14. Kinghorn A, Compadre C. Alternative Sweeteners. 3rd ed. Boca Raton, FL: CRC Press; 2001.
  15. Chan P, Tomlinson B, Chen YJ, Liu JC, Hsieh MH, Cheng JT. A double‐blind placebo‐controlled study of the effectiveness and tolerability of oral stevioside in human hypertension. Br J Clin Pharmacol. 2000;50(3):215–220.
  16. Lee CN, Wong KL, Liu JC, Chen YJ, Cheng JT, Chan P. Inhibitory effect of stevioside on calcium influx to produce antihypertension. Planta Med. 2001;67(9):796–799.
  17. Jeppesen PB, Gregersen S, Alstrup K, Hermansen K. Stevioside induces antihyperglycaemic, insulinotropic and glucagonostatic effects in vivo: Studies in the diabetic Goto–Kakizaki (GK) rats. Phytomed. 2002;9(1):9–14.
  18. Jeppesen PB, Gregersen S, Poulsen C, Hermansen K. Stevioside acts directly on pancreatic β cells to secrete insulin: Actions independent of cyclic adenosine monophosphate and adenosine triphosphate–sensitivie K+-channel activity. Metabolism. 2000;49(2):208–214.
  19. Das S, Das A, Murphy R, Punwani I, Nasution M, Kinghorn A. Evaluation of the cariogenic potential of the intense natural sweeteners stevioside and rebaudioside A. Caries Res. 1992;26(5):363–366.
  20. Parsons WT, Parsons WT, Cuthbertson E. Noxious Weeds of Australia. Clayton, Australia: CSIRO Publishing; 2001.
  21. Seager H. Drug‐delivery products and the Zydis fast‐dissolving dosage form. J Pharm Pharmacol. 1998;50(4):375–382.
  22. Chapter G. <1174> Powder flow. USP33-NF28. 2010. https://www.scribd.com/document/374151661/0801-0804-1174-POWDER-FLOW-USP-35 (Accessed on March 22, 2019).
  23. Rockville M. United States Pharmacopoeia. Paper presented at: United States Pharmacopoeial Convention Inc., Washington, Washington D.C., 2002.
  24. Barathi N. Sweeter alternative. Times Agri J. 2003;14.
  25. Revision USPCCo. The United States Pharmacopeia 42; 2019.
  26. Shah NH, Ahmed HA. Content uniformity of a low dose pharmaceutical product. Particul Sci Technol. 1997;15(2):151–151.
  27. Matinez L, Tchoreloff P, Leclerc B, Besnard M, Couarraze G. Active layering and direct compression of sugar spheres: Content homogeneity in low-dosage tablets. Pharm Technol Eur. 2001;38–46.